Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * SEROUSSI YAIR 2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026 3. Issuer Name and Ticker or Trading Symbol STRATASYS LTD. [SSYS] (Last) (First) (Middle) C/O STRATASYS LTD., 1 HOLTZMAN STREET, SCIENCE PARK 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) REHOVOT 76124 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Ordinary shares 19,948 D Ordinary shares(1) 6,113 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)	07/18/2018	07/18/2027	Ordinary shares	10,000	$23.41	D
Stock Option (right to buy ordinary shares)	09/13/2019	09/13/2028	Ordinary shares	10,000	$21.82	D
Stock Option (right to buy ordinary shares)	12/31/2020	12/31/2029	Ordinary shares	10,000	$20.53	D
Stock Option (right to buy ordinary shares)	11/30/2021	11/30/2030	Ordinary shares	10,000	$19.61	D
Stock Option (right to buy ordinary shares)	11/23/2022	11/23/2031	Ordinary shares	4,745	$25.03	D
Stock Option (right to buy ordinary shares)	12/26/2023	12/26/2032	Ordinary shares	11,326	$6.18	D
Stock Option (right to buy ordinary shares)	08/08/2024	08/08/2033	Ordinary shares	6,829	$10.25	D
Stock Option (right to buy ordinary shares)	11/07/2025	11/07/2034	Ordinary shares	12,833	$9.32	D
Stock Option (right to buy ordinary shares)	(2)	09/30/2035	Ordinary shares	11,056	$11.45	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
SEROUSSI YAIR C/O STRATASYS LTD. 1 HOLTZMAN STREET, SCIENCE PARK REHOVOT 76124	X

Signatures

/s/ Vered Ben Jacob, attorney-in-fact		03/18/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on September 30, 2025 and that vest and settle for underlying ordinary shares in 12 equal monthly installments over a vesting period that commenced on July 18, 2025 and will conclude on the one-year anniversary of the vesting commencement date (July 18, 2026), by which time all such RSUs will be fully vested (and underlying ordinary shares issued).
(2)	The options reported in this row were granted to the Reporting Person by the Issuer on September 30, 2025 and vest and become exercisable in 12 equal monthly installments over a vesting period that commenced on July 18, 2025 and will conclude on the one-year anniversary of the vesting commencement date (July 18, 2026), by which time all options reported in this row will be vested and exercisable.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.